Bmi-1 maintains and/or promotes the self-renewal of cancer stem-like cells/tumor-initiating cells in a variety of tumors [9–21], and thus is an ideal target for treatments aimed at cancer stem-like cells. The gene discussed is BMI1; the disease is neoplasm.